MRKR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Marker Therapeutics Inc (MRKR) is not a strong buy for a beginner, long-term investor at this time. The lack of positive financial performance, absence of trading signals, and no significant news or catalysts make it a hold for now.
The MACD is slightly positive, suggesting mild bullish momentum. RSI is neutral at 51.412, indicating no clear overbought or oversold conditions. Moving averages are converging, showing no strong trend. Key resistance is at 1.426, and support is at 1.212.
NULL identified. No recent news or significant trading trends.
The company reported a significant YoY decline in revenue (-51%), net income (-55.62%), and EPS (-78.57%) in Q4 2025, indicating poor financial health.
In Q4 2025, revenue dropped to $1,103,444 (-51% YoY), net income fell to -$1,703,210 (-55.62% YoY), and EPS decreased to -0.09 (-78.57% YoY). Gross margin remained stable at 100%.
No recent analyst ratings or price target changes available.
